Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Villani

Showing results (41-50 of 103) with videos related to

Pageof 11
Sort By:
Arzneimittel-Forschung|April 1, 1996
Clinical and pharmacokinetic evaluation of a new lipid-based delivery system of amphotericin B in AIDS patientsP Villani, M B Regazzi, R Maserati, et al.
La Clinica Terapeutica|June 1, 1996
[Role of clinical pharmacology in the monitoring of therapy of HIV-infected subjects]P Villani, L Cocchi, R Giacchino, et al.
Mutagenesis|November 4, 1998
Measurement and characterization of micronuclei in cultured primary lung cells of mice following inhalation exposure to benzeneR Ranaldi, B Bassani, P Villani, et al.
Annales De Readaptation Et De Medecine Physique : Revue Scientifique De La Societe Francaise De Reeducation Fonctionnelle De Readaptation Et De Medecine Physique|April 3, 2004
[General practitioners' health care for disabled patients: a survey among a panel of general practitioners in Southeastern France, in 2002]M Aulagnier, J C Gourheux, A Paraponaris, et al.
Circulation|March 17, 1999
Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine modelA Kumar, M P Villani, U K Patel, et al.
Mutation Research|February 19, 1999
Micronucleated lymphocyte rates from head-and-neck cancer patientsF Duffaud, T Orsière, L Digue, et al.
British Journal of Clinical Pharmacology|May 8, 1999
Pharmacokinetic variability and strategy for therapeutic drug monitoring of saquinavir (SQV) in HIV-1 infected individualsM B Regazzi, P Villani, R Maserati, et al.
Annales De Biologie Clinique|March 21, 1998
[Application of micronucleus test for the demonstration of antimutagenic properties of natural substances]P Villani, T Orsière, E Bartfai, et al.
British Journal of Clinical Pharmacology|December 14, 1999
Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patientsP Villani, M B Regazzi, F Castelli, et al.
Therapeutic Drug Monitoring|July 31, 2001
Antiretrovirals: simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography--mass spectrometry assayP Villani, M Feroggio, L Gianelli, et al.
Pageof 11

Showing results (41-50 of 103) with videos related to

Sort By:
Pageof 11
Arzneimittel-Forschung|April 1, 1996
Clinical and pharmacokinetic evaluation of a new lipid-based delivery system of amphotericin B in AIDS patientsP Villani, M B Regazzi, R Maserati, et al.
La Clinica Terapeutica|June 1, 1996
[Role of clinical pharmacology in the monitoring of therapy of HIV-infected subjects]P Villani, L Cocchi, R Giacchino, et al.
Mutagenesis|November 4, 1998
Measurement and characterization of micronuclei in cultured primary lung cells of mice following inhalation exposure to benzeneR Ranaldi, B Bassani, P Villani, et al.
Annales De Readaptation Et De Medecine Physique : Revue Scientifique De La Societe Francaise De Reeducation Fonctionnelle De Readaptation Et De Medecine Physique|April 3, 2004
[General practitioners' health care for disabled patients: a survey among a panel of general practitioners in Southeastern France, in 2002]M Aulagnier, J C Gourheux, A Paraponaris, et al.
Circulation|March 17, 1999
Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine modelA Kumar, M P Villani, U K Patel, et al.
Mutation Research|February 19, 1999
Micronucleated lymphocyte rates from head-and-neck cancer patientsF Duffaud, T Orsière, L Digue, et al.
British Journal of Clinical Pharmacology|May 8, 1999
Pharmacokinetic variability and strategy for therapeutic drug monitoring of saquinavir (SQV) in HIV-1 infected individualsM B Regazzi, P Villani, R Maserati, et al.
Annales De Biologie Clinique|March 21, 1998
[Application of micronucleus test for the demonstration of antimutagenic properties of natural substances]P Villani, T Orsière, E Bartfai, et al.
British Journal of Clinical Pharmacology|December 14, 1999
Pharmacokinetics of efavirenz (EFV) alone and in combination therapy with nelfinavir (NFV) in HIV-1 infected patientsP Villani, M B Regazzi, F Castelli, et al.
Therapeutic Drug Monitoring|July 31, 2001
Antiretrovirals: simultaneous determination of five protease inhibitors and three nonnucleoside transcriptase inhibitors in human plasma by a rapid high-performance liquid chromatography--mass spectrometry assayP Villani, M Feroggio, L Gianelli, et al.
Pageof 11